BIG PHARMA WATCH: REPORT FINDS BIG PHARMA’S “PERVASIVE” PATENT ABUSE “THE ROOT OF THE DRUG PRICING CRISIS”
I-MAK Analysis Finds Anti-Competitive Practices That Extend Exclusivity Will… Read More
© 2026 CSRXP- All Rights Reserved
CSRXP: MODERNA MUST BE PUT ON NOTICE THAT PATIENTS, POLICYMAKERS WOULD FIND SIX-FOLD VACCINE PRICE HIKE UNCONSCIONABLE
Big Pharma Giant Eyes Massive Price Hike on COVID-19 Vaccine Developed with… Read More
BIG PHARMA WATCH: STUDY FINDS BIG PHARMA PROFITS THROUGH ANTI-COMPETITIVE KICKBACK SCHEMES CLOAKED AS CHARITY
Researchers Say Brand Name Drug Companies’ So-Called Patient Assistance… Read More
SECOND OPINION: AVIK ROY DEBUNKS BIG PHARMA’S INNOVATION RHETORIC
FREOPP President Explains Pharmaceutical Industry Arguments Are “Factually… Read More
DOSE OF REALITY: REPORT FINDS RX SPENDING CONTINUED TO RISE AS BIG PHARMA MAINTAINED BUSINESS-AS-USUAL APPROACH TO PRICE-GOUGING
Analysis Highlights How Escalating Prescription Drug Costs, Driven By Big… Read More
CSRXP APPLAUDS PRESIDENT BIDEN FOR TAKING MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE
Biden Administration and Congress Deliver Positive Progress on Longstanding… Read More
BIG PHARMA WATCH: DRUG COMPANIES ON PACE FOR RECORD 2022 LAUNCH PRICES
Analysis Finds Brand Name Manufacturers Bringing New Drugs to Market with… Read More
CSRXP: CONGRESS TAKES MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE, LOWERING DRUG PRICES FOR THE AMERICAN PEOPLE
Big Pharma Can No Longer Evade Accountability and Keep Prices High by Spending… Read More
ICYMI: OPINION: DRUG COMPANIES ARE WARNING THAT PRICING REFORM SPELLS DOOM. DON’T FALL FOR IT
Washington Post Op-ed Debunks Bogus Big Pharma Claims That Solutions to Lower… Read More
CSRXP APPLAUDS SENATE FOR MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE AND LOWERING PRESCRIPTION DRUG PRICES
Drug Pricing Solutions in Inflation Reduction Act of 2022 Will Help Crack Down… Read More
BIG PHARMA EARNINGS WATCH: ABBVIE, ASTRAZENECA, AMGEN
Big Pharma Drugmakers Top Wall Street Estimates After Hiking Drug Prices… Read More
SECOND OPINION: PHRMA’S LAST-DITCH ATTEMPT TO DERAIL SOLUTIONS TO LOWER DRUG PRICES REHASHES DEBUNKED ARGUMENTS
Pharmaceutical Industry Attempts to Intimidate Lawmakers and Keep Prices High… Read More